Genentech Will Alert Physicians To Raptiva Anemia Warning

"Dear Healthcare Provider" letter will address a hemolytic anemia warning stemming from postmarketing surveillance of the plaque psoriasis therapy. A precaution on severe arthritis events also has been added.